Jianghua Hu

Ms. Jianghua Hu

Jiande Branch of The The Second Affiliated Hospital, Zhejiang university school of medcine, Hangzhou, Zhejiang, China
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JHJianghua Hu
Jianghua Hu
YYYibo Yu
Yibo Yu
Thioredoxin‐binding protein‐2 (TBP‐2) has an important role in the redox system, but it plays a different role in many different diseases (e.g., various cancers, diabetes mellitus (DM), cardiovascular disease, and cataracts) by influencing cell proliferation, differentiation, apoptosis, autophagy, and metabolism. Distinct transcription factors (TFs) stimulated by different factors combine with binding sites or proteins to upregulate or downregulate TBP‐2 expression, in order to respond to the change in the internal environment. Most research disclosed that the main function of TBP‐2 is associating with thioredoxin (Trx) to inhibit the antioxidant capacity of Trx. Furthermore, the TBP‐2 located in tissues, whether normal or abnormal, has the ability to cause the dysfunctioning of cells and even death through different pathways, such as shortening the cell cycle and inducing apoptosis or autophagy. Through these studies, we found that TBP‐2 promoted the development of diseases which are involved in inflammatory and oxidative damage. To a certain extent, we believe that there is some hidden connection between the biological functions which TBP‐2 participates in and some distinct diseases. This review presents only a summary of the roles that TBP‐2 plays in cancer, DM, cataracts, and so on, as well as its universal mechanisms. Further investigations are needed for the cell signaling pathways of the effects caused by TBP‐2. A greater understanding of the mechanisms of TBP‐2 could produce potential new targets for the treatment of diseases, including cancer and diabetes, cardiovascular disease, and cataracts.

25 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YZYidong Zhang
Yidong Zhang
CZChengshou Zhang
Chengshou Zhang
SCSilong Chen
Silong Chen
JHJianghua Hu
Jianghua Hu
LSLifang Shen
Lifang Shen
YYYibo Yu
Yibo Yu
Posterior capsular opacification (PCO) is the most common complication resulting from cataract surgery and limits the long-term postoperative visual outcome. Using Nd:YAG laser-assisted posterior capsulotomy for the clinical treatment of symptomatic PCO increases the risks of complications, such as glaucoma, retinal diseases, uveitis, and intraocular lens (IOL) pitting. Therefore, finding how to prevent PCO development is the subject of active investigations. As a replacement organ, the IOL is implanted into the lens capsule after cataract surgery, but it is also associated with the occurrence of PCO. Using IOL as a medium for PCO prophylaxis is a more facile and efficient method that has demonstrated various clinical application prospects. Thus, scientists have conducted a lot of research on new intraocular lens fabrication methods, such as optimizing IOL materials and design, and IOL surface modification (including plasma/ultraviolet/ozone treatment, chemical grafting, drug loading, coating modification, and layer-by-layer self-assembly methods). This paper summarizes the research progress for different types of intraocular lenses prepared by different surface modifications, including anti-biofouling IOLs, enhanced-adhesion IOLs, micro-patterned IOLs, photothermal IOLs, photodynamic IOLs, and drug-loading IOLs. These modified intraocular lenses inhibit PCO development by reducing the residual intraoperative lens epithelial cells or by regulating the cellular behavior of lens epithelial cells. In the future, more works are needed to improve the biosecurity and therapeutic efficacy of these modified IOLs.

22 January 2018 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
XXXin Xie
Xin Xie
JHJianghua Hu
Jianghua Hu
GSGuizhen Sun
Guizhen Sun
BDBo Ding
Bo Ding
LFLei Feng
Lei Feng
Sparganosis is one of the neglected but important food-borne parasitic zoonoses, with higher prevalence in Asian countries. The infection is commonly located in the subcutaneous tissue, brain, breast, and lung, but fewer reported infections involve the eye. Because the majority of patients with sparganosis are adults, it is likely to be missed in children. An 8-year-old boy presented to our clinic complaining of a painless ocular mass in his right eye for 1 month. The boy had a history of eating frogs and frog poultice applications to his eyelids. The patient was checked for an elliptical mass near the medial wall of the right eye. Serodiagnosis testing was positive in an enzyme-linked immunosorbent assay. During surgical operation on the patient, calcified parasite eggs and foreign body granulomatous reaction were found using histological examination. Due to early detection and surgery, the patient fully recovered with no damage to his eyesight. Although rare, ocular sparganosis should be suspected in a mass of the eye when there is a history of eating frogs and frog poultice applications on eyelids. Early surgical resection is important for a good prognosis.

5 March 2023 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
JHJianghua Hu
Jianghua Hu
JLJinxia Liu
Jinxia Liu
SCSilong Chen
Silong Chen
CZChengshou Zhang
Chengshou Zhang
LSLifang Shen
Lifang Shen
YYYibo Yu
Yibo Yu

1 January 2017
Verified
Conference Paper
Open access
PDF file
QJQi Jia
Qi Jia
XYXitong Yang
Xitong Yang
WXWeidong Xu
Weidong Xu
XLXuliang Lv
Xuliang Lv
JHJianghua Hu
Jianghua Hu

19 October 2016
Verified
Conference Paper
Closed access
PDF file
JHJianghua Hu
Jianghua Hu
CJChaochao Jian
Chaochao Jian
GCGuangzhen Cui
Guangzhen Cui
XLXuliang Lv
Xuliang Lv
XRXianhui Rong
Xianhui Rong